Barclays cuts Equity Residential stock rating on merger concerns

Barclays cuts Equity Residential stock rating on merger concerns

US concludes third round of strikes against Iran after Trump reinstates blockade Investing.com - Barclays downgraded Equity Residential (NYSE:EQR) to Equalweight from Overweight and set a price target of $76.00. The stock currently trades at $69.72, near its 52-week high of $71.50, giving Barclays’ target modest upside of around 9%. Analyst Richard Hightower cited minimal expected funds from operations accretion from the company’s previously announced merger as a primary reason for the downgrade.

The merger is expected to close later this year. Barclays also pointed to a perceived lack of enthusiasm among REIT-dedicated investors for the deal. The firm downgraded AvalonBay Communities alongside Equity Residential.

The analyst now applies a 10% discount to fair net asset value for both companies, compared with 5% for the remainder of Barclays’ multifamily coverage. The change reflects the firm’s revised view on the merger’s near-term financial impact. Equity Residential operates as a real estate investment trust focused on multifamily properties.

With a market cap of $26.8 billion and a dividend yield of 4.03%, the company has maintained dividend payments for 34 consecutive years. According to InvestingPro analysis, the stock appears overvalued at current levels. Investors can explore more insights through the comprehensive Pro Research Report, available for EQR and 1,400+ other US equities.

In other recent news, Equity Residential reported its first-quarter 2026 earnings. The company held its annual meeting of shareholders, where all ten nominees for the board of trustees were elected for one-year terms. In a significant development, Equity Residential announced plans to merge with AvalonBay Communities, forming a $69 billion coastal apartment company.

Following this announcement, Stifel raised its price target for Equity Residential shares to $79.00 while maintaining a Buy rating. Piper Sandler reiterated an Overweight rating with a $78.00 price target, noting that the merger aligns with initial analysis. These developments highlight the company’s strategic moves and shareholder support.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.